"Dr. Prins was discussing those subtypes that did not necessarily respond to DCVax-L when he discussed the striking results of combo treatment -- PD-1 inhibitors + DCVax-L. IMHO." Flipper
Okay, I didn't realize that Prins mentioned about ANY data on combo treatments in HUMANS. I'm assuming you are talking about their striking results in murine model. Makes you wonder what the potential of DCVAX-L as a monotherapy based on the results of that murine model. BTW when you mispelled murine as maurine, I'm assuming it was the iphone spell check anomoly- am I correct?
BTW I've been stating the need for combo treatments way longer than this board or the general public. You guys are a little late to join the bandwagon. Unfortunately for you guys, NWBO is even later than most other companies. At least some of them are doing combo studies without waiting for the collaboration or partnerships to form first. I will wait for NWBO to PR this latest UCLA/BMY collaboration to see if they are playing a part in this or not.
News 
Market Data 
Discover 
AI
